静脉注射咖啡因增强剂在电治疗中的有效性和安全性
Magdalena D Ridder1,2, Sarah Ulrich1,2, Richard Vettermann1,2
1Experimental Cognitive and Clinical Affective Neuroscience (ECAN) Laboratory, Department of Clinical Research (DKF), University of Basel, Switzerland.
Neuroscience applied
|November 14, 2025
概括
在电疗法 (ECT) 中增加咖啡因酸盐显著增加了发作的长度和减少了能量需求. 这一策略提高了ECT的有效性和安全性,而不会影响心血管标志物.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 电疗法 (ECT) 是严重精神疾病的重要神经调节治疗方法.
- 在ECT期间保持足够的发作时间对于治疗疗效至关重要.
- 在ECT会话中逐渐缩短发作时间需要增加能量,可能会增加副作用风险.
研究的目的:
- 调查静脉注射咖啡因酸盐对ECT期间发作质量的影响.
- 评估咖啡因增强是否可以增强电脑电图 (EEG) 发作的长度,并减少能量需求.
- 评估咖啡因作为ECT增强策略的安全性和有效性.
主要方法:
- 一项回顾性研究分析了69名患者的276次ECT疗程.
- 在服用咖啡因酸盐 (200毫克) 之前和之后比较的发作指标 (EEG发作长度,心率峰值,能量设置).
- 对麻醉作用及其相互作用进行控制,以隔离咖啡因的影响.
主要成果:
- 咖啡因增加显著增加了EEG发作的长度 (p < 0.001).
- 显著降低了ECT所需的能量 (p < 0.001).
- 没有观察到高峰心率或其他副作用的显著变化.
结论:
- 静脉注射咖啡因酸盐可以安全地增加ECT中的发作时间.
- 咖啡因减缓了连续ECT会话所需的能量增加.
- 这支持咖啡因作为一种有效的增强策略,以提高ECT的疗效和患者的治疗结果.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.6K
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.7K
相关概念视频
01:30Electroconvulsive Therapy
835
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
835
01:20Antiepileptic Drugs: Potassium Channel Activators
616
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
616